Table 2.
Impact of MetS and its individual components on stroke short-term outcomes
| MetS | Hyperglycemia | Hypertension | Low HDL-C | Elevated TG | Elevated WC | No. of Components | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | p | OR | 95 % CI | p | OR | 95 % CI | p | OR | 95 % CI | p | OR | 95 % CI | p | OR | 95 % CI | p | OR | 95 % CI | p | OR | 95 % CI | |
| 30 days after the onset | ||||||||||||||||||||||
| mRS ≥3 | 229 | 0.788 | 0.95 | 0.64 ~ 1.35 | <0.001 | 2.03 | 1.02 ~ 1.06 | 0.847 | 0.85 | 0.47 ~ 1.53 | 0.12 | 0.76 | 0.54 ~ 1.07 | 0.001 | 0.46 | 0.29 ~ 0.72 | 0.485 | 0.87 | 0.59 ~ 1.28 | 0.568 | 0.96 | 0.82 ~ 1.11 |
| BI <60 | 231 | 0.514 | 1.12 | 0.79 ~ 1.59 | <0.001 | 2.10 | 1.48 ~ 2.99 | 0.618 | 0.86 | 0.48 ~ 1.55 | 0.12 | 0.76 | 0.53 ~ 1.08 | <0.001 | 0.40 | 0.25 ~ 0.64 | 0.224 | 0.35 | 0.99 ~ 1.03 | 0.4.02 | 1.06 | 0.92 ~ 1.24 |
| Death | 23 | 0.805 | 1.16 | 0.44 ~ 2.85 | 0.010 | 3.34 | 1.33 ~ 8.35 | 0.014 | 0.25 | 0.09 ~ 0.76 | 0.612 | 1.25 | 0.52 ~ 2.99 | 0.064 | 0.15 | 0.02 ~ 1.12 | 0.647 | 0.80 | 0.31 ~ 2.05 | 0.608 | 0.91 | 0.63 ~ 1.31 |
| Recurrence | 31 | 0.084 | 0.52 | 0.24 ~ 1.09 | 0.801 | 0.91 | 0.43 ~ 1.94 | 0.957 | 0.97 | 0.28 ~ 3.36 | 0.35 | 1.43 | 0.68 ~ 3.01 | 0.156 | 0.41 | 0.12 ~ 1.41 | 0.157 | 0.57 | 0.27 ~ 1.24 | 0.221 | 0.82 | 0.59 ~ 1.13 |
| 90 days after the onset | ||||||||||||||||||||||
| mRS ≥3 | 221 | 0.387 | 0.86 | 0.60 ~ 1.22 | <0.001 | 2.01 | 1.41 ~ 2.85 | 0.436 | 0.79 | 0.44 ~ 1.43 | 0.030 | 0.68 | 0.48 ~ 0.96 | 0.002 | 0.49 | 0.33 ~ 0.78 | 0.262 | 0.80 | 0.54 ~ 1.18 | 0.334 | 0.93 | 0.80 ~ 1.08 |
| BI <95 | 226 | 0.502 | 1.13 | 0.80 ~ 1.60 | <0.001 | 2.12 | 1.49 ~ 3.02 | 0.523 | 0.83 | 0.46 ~ 1.49 | 0.092 | 0.74 | 0.53 ~ 1.05 | 0.002 | 0.50 | 0.31 ~ 0.78 | 0.212 | 0.78 | 0.53 ~ 1.15 | 0.531 | 1.05 | 0.90 ~ 1.22 |
| Death | 39 | 0.225 | 0.63 | 0.30 ~ 1.33 | 0.025 | 2.18 | 1.10 ~ 4.31 | 0.099 | 0.45 | 0.17 ~ 1.16 | 0.855 | 1.07 | 0.54 ~ 2.11 | 0.061 | 0.31 | 0.09 ~ 1.05 | 0.097 | 0.55 | 0.28 ~ 1.11 | 0.223 | 0.83 | 0.62 ~ 1.11 |
| Recurrence | 51 | 0.984 | 1.02 | 0.56 ~ 1.86 | 0.775 | 0.92 | 0.51 ~ 1.66 | 0.870 | 0.92 | 0.35 ~ 2.46 | 0.248 | 1.42 | 0.78 ~ 2.59 | 0.698 | 1.15 | 0.57 ~ 2.35 | 0.708 | 0.88 | 0.45 ~ 1.71 | 0.611 | 1.07 | 0.83 ~ 1.38 |
Univariate binary logistic regression analysis was used to assess following variables, MetS, hyperglycemia, hypertension, low HDL-C, elevated TG and high WC to the contribution of stroke prognosis
MetS metabolic syndrome, HDL-C high density lipoprotein cholesterol, TG triglyceride, WC waist circumference, mRS modified Rankin Scale, BI barthal index, OR odds ratios, CI confidence interval